— Know what they know.
Not Investment Advice

Financial News

Sentiment 43.1 5419 articles 2840 bullish 1163 bearish Full Index →
Spectral AI Stock Jumps After $31.7 Million Funding Award

Spectral AI Stock Jumps After $31.7 Million Funding Award

Spectral AI Inc (NASDAQ:MDAI) stock is trading higher Thursday morning after the medical diagnostics company said it received $31.7 million in new...
📰

Home Telecom Completes High-Split HFC Modernization with Teleste and Mega Hertz

Deployment of Teleste ICON intelligent amplifiers and Argus NMS strengthens reliability, improves operational visibility, and prepares the network...
📰

Micron's 'Stunning' Q2: Record Margins, Tight Supply And 5‑Year AI Deals

Micron Technology, Inc. (NASDAQ:MU) delivered a massive fiscal Q2 beat and far stronger-than-expected Q3 guidance, triggering a wave of bullish...
📰

Home Telecom Completes High-Split HFC Modernization with Teleste and Mega Hertz

Deployment of Teleste ICON intelligent amplifiers and Argus NMS strengthens reliability, improves operational visibility, and prepares the network...
📰

Best Low-Beta Stocks to Own Right Away: AGRO, PRA, E & LQDA

Low-beta picks gain focus as Iran war fears stir volatility. AGRO, PRA, E and LQDA reflect resilience with momentum, liquidity and fundamentals.
Pfizer Combo Therapy Scores Major Win In Prostate Cancer Tri

Pfizer Combo Therapy Scores Major Win In Prostate Cancer Trial

Pfizer Inc. (NYSE:PFE) shares are up during Thursday’s trading session after the company shared data from Talzenna plus Xtandi’s...
Here's Why You Should Hold Solventum Stock in Your Portfolio

Here's Why You Should Hold Solventum Stock in Your Portfolio Now

SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
Here's Why You Should Hold Solventum Stock in Your Portfolio

Here's Why You Should Hold Solventum Stock in Your Portfolio Now

SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
Here's Why You Should Hold Solventum Stock in Your Portfolio

Here's Why You Should Hold Solventum Stock in Your Portfolio Now

SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
📰

Is It Too Late to Buy Eli Lilly?

Eli Lilly's GLP-1 drugs are leaders in a new and exciting drug category, but investors already know this fact.
Here's Why You Should Hold Solventum Stock in Your Portfolio

Here's Why You Should Hold Solventum Stock in Your Portfolio Now

SOLV rides on strong segment demand, innovation push and cost savings plan, but tariffs and rising input costs cloud margin outlook.
📰

Is It Too Late to Buy Eli Lilly?

Eli Lilly's GLP-1 drugs are leaders in a new and exciting drug category, but investors already know this fact.
📰

Is It Too Late to Buy Eli Lilly?

Eli Lilly's GLP-1 drugs are leaders in a new and exciting drug category, but investors already know this fact.
Re:Build Cadonix Arcadia and smartBuild Selected by CNH to H

Re:Build Cadonix Arcadia and smartBuild Selected by CNH to Help Enhance Wire Harness Design and Manufacturing

FRAMINGHAM, Mass., March 19, 2026 /PRNewswire/ -- CNH, a world-class equipment, technology and services company specializing in Agriculture and...
Salient CRGT, Inc., a wholly owned subsidiary of GovCIO Wins

Salient CRGT, Inc., a wholly owned subsidiary of GovCIO Wins U.S. Navy Contract to Enhance RSNF Training, Logistics, and Operational Effectiveness

FAIRFAX, Va., March 19, 2026 /PRNewswire/ -- GovCIO, a leader in mission‑focused technology, training, and operational support for the federal...
📰

The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology

Issued on behalf of Oncolytics Biotech Inc. Issued on behalf of Oncolytics Biotech Inc.
Reasons to Retain Avanos Medical Stock in Your Portfolio for

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.
Reasons to Retain Avanos Medical Stock in Your Portfolio for

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.
Reasons to Retain Avanos Medical Stock in Your Portfolio for

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.
Reasons to Retain Avanos Medical Stock in Your Portfolio for

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

AVNS gains on strong SNS and PMR growth, M&A and cost actions, but tariff risks and segment headwinds may weigh on near-term performance.
📰

Biofrontera (BFRI) Q4 2025 Earnings Transcript

Image source: The Motley Fool.Thursday, March 19, 2026 at 10 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
GEHC & Springbok Collaborate on MRI Muscle Analysis for Spor

GEHC & Springbok Collaborate on MRI Muscle Analysis for Sports

GE HealthCare teams with Springbok to pair MRI tech with AI muscle analytics, aiming to redefine how muscle health is measured and visualized.
GEHC & Springbok Collaborate on MRI Muscle Analysis for Spor

GEHC & Springbok Collaborate on MRI Muscle Analysis for Sports

GE HealthCare teams with Springbok to pair MRI tech with AI muscle analytics, aiming to redefine how muscle health is measured and visualized.
GEHC & Springbok Collaborate on MRI Muscle Analysis for Spor

GEHC & Springbok Collaborate on MRI Muscle Analysis for Sports

GE HealthCare teams with Springbok to pair MRI tech with AI muscle analytics, aiming to redefine how muscle health is measured and visualized.
GEHC & Springbok Collaborate on MRI Muscle Analysis for Spor

GEHC & Springbok Collaborate on MRI Muscle Analysis for Sports

GE HealthCare teams with Springbok to pair MRI tech with AI muscle analytics, aiming to redefine how muscle health is measured and visualized.
Sieyuan Electric Secured Over 4.5 GWh Energy Storage Agreeme

Sieyuan Electric Secured Over 4.5 GWh Energy Storage Agreements in Romania, Advancing Global Market Expansion

BUCHAREST, Romania, March 19, 2026 /PRNewswire/ -- Sieyuan Electric, a global leader in power technology and energy storage solutions, announced the...
Re:Build Cadonix Arcadia and smartBuild Selected by CNH to H

Re:Build Cadonix Arcadia and smartBuild Selected by CNH to Help Enhance Wire Harness Design and Manufacturing

FRAMINGHAM, Mass., March 19, 2026 /PRNewswire/ -- CNH, a world-class equipment, technology and services company specializing in Agriculture and...
Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

ALNY's strong drug sales and advancing pipeline, including late-stage candidates, are driving momentum and supporting its long-term growth outlook.
Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

ALNY's strong drug sales and advancing pipeline, including late-stage candidates, are driving momentum and supporting its long-term growth outlook.
Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

ALNY's strong drug sales and advancing pipeline, including late-stage candidates, are driving momentum and supporting its long-term growth outlook.
Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

ALNY's strong drug sales and advancing pipeline, including late-stage candidates, are driving momentum and supporting its long-term growth outlook.
📰

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—MASI, AVO, CVGW, and TPH

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action...
📰

URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger—MASI, AVO, CVGW, and TPH

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action...
📰

$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote—TALK, UNF, ACLX, and FONR

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action...
📰

$HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote—TALK, UNF, ACLX, and FONR

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action...
What's Going On With Cheniere Energy Stock Today?

What's Going On With Cheniere Energy Stock Today?

Cheniere Energy, Inc. (NYSE:LNG) shares are trading higher on Thursday, benefiting from ongoing global LNG supply disruptions while also gaining...
WeRide Storms Slovakia With Nation's First Autonomous Drivin

WeRide Storms Slovakia With Nation's First Autonomous Driving Rollout

WeRide Inc. (NASDAQ:WRD) announced Thursday it has entered Slovakia through a partnership with ELEVATE Slovakia, launching the country’s first...
Best Momentum Stocks to Buy for March 19th

Best Momentum Stocks to Buy for March 19th

FIGS, QTTB and NESR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 19, 2026.
📰

Are Options Traders Betting on a Big Move in Harmony Biosciences Stock?

Investors need to pay close attention to Harmony Biosciences stock based on the movements in the options market lately.
Why Are Semiconductor Chip Stocks Falling On Thursday?

Why Are Semiconductor Chip Stocks Falling On Thursday?

Semiconductor stocks pulled back on Thursday amid geopolitical tensions and supply risks, adding fresh pressure to an already sensitive sector. The...
📰

Taysha (TSHA) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.Thursday, March 19, 2026 at 8:30 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
« Prev 1 75 76 77 78 79 82 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms